Skip Ribbon Commands
Skip to main content

Pharma RFP/Invitation Notices

Terms and Conditions: 

  1. All RFP proposals must be submitted through the Ariba sourcing tool.
  2. Your company must be registered in Singapore to participate in ALPS events.
  3. For all events, the Supply Head requirement for participation is EPU/DAP/32.
  4. Each Company must participate at all sourcing events through or using the same Ariba account. 

You can gain direct access into events by following the steps outlined below:
  • Click on the respective link found in the column “Respond to Posting”. You will be directed to the next page
  • Click on the “Respond to Posting” button found on the page
  • Log in to Ariba by entering your Ariba ID and password
  • You will gain access into the event for proposal submission
  • Submit your proposal in the Ariba sourcing tool before the closing date and time stated in the RFP notice below ​ 

Contact Persons:

Chua Chye Juan (Tel: 6377 8733)
Maimunah ​Abdul Rahman (Tel: 6377 8732)
Nor'ain Mohd Yusoff (Tel: 6377 8734)  ​

Purchasing Programme

Evaluation Criteria

RFP Results (Updated on 16 August 2019)


RFP/Invitation Notices

  
Event Description
  
  
  
  
  
  
Remarks
GPOR 29219

​Item 1 – Intravenous Immune Globulin for Intravenous use 2.5g (single dose vial)
Item 2 – Intravenous Immune Globulin for Intravenous use 5g (single dose vial)
Item 3 – Intravenous Immune Globulin for Intravenous use 10g (single dose vial)

GPOR 2921916/08/20196/9/2019 12:00 PMhttp://discovery.ariba.com/rfx/7145835S9 or HigherNo
GPOR 29119

​Item 1 – High purity Factor VIII concentrate containing approximately 250 IU per vial for the treatment of Factor VIII deficiency (single dose vial)
Item 2 – Factor VIII Concentrate with von Willebrand’s Factor containing approximately 250-280 units per vial, for treatment of von Willebrand’s Disease (single dose vial)
Item 3 - High purity Factor IX concentrate containing approximately 500 IU per vial for the treatment of Factor IX deficiency

GPOR 29119 16/08/20196/9/2019 12:00 PM http://discovery.ariba.com/rfx/7145733S4 or HigherNo
GPOR 29019

​Item 1 – Anti-D (Rho) Immune Globulin (Human) 300mcg/dose Injection
Item 2 – Hepatitis B Immune Globulin (Human), 0.5ml vial
Item 3 – Hepatitis B Immune Globulin (Human), 5ml vial
Item 4 – Human Rabies Immune Globulin 300 IU/2ml Injection
Item 5 – Human Tetanus Immune Globulin 250 IU Injection

GPOR 2901916/08/20196/9/2019 12:00 PMhttp://discovery.ariba.com/rfx/7145596S3 or HigherYes

​This is due to WHC quantity is missed out from Items 3 and 5 of the RFP. Therefore the total quantity for Items 3 and 5 need to be changed from 171 to 172 vials and 113 to 115 vials.

GPOR 28919

​Item 1 – Human Albumin Solution 5% w/v for intravenous administration, 250ml vial
Item 2 – Human Albumin Solution 20% w/v for intravenous administration, 50ml vial

GPOR 2891916/08/20196/9/2019 12:00 PMhttp://discovery.ariba.com/rfx/7145495S7 or HigherNo
GPOR 28819

​Item 1 – Coombs Reagent, Anti-Human Globulin (Polyspecific), 10ml bottle

GPOR 2881916/08/20196/9/2019 12:00 PMhttp://discovery.ariba.com/rfx/7145022S2 or HigherNo
GPOR 28719

​Item 1 – Anti-A Blood Grouping Serum, 10ml bottle
Item 2 – Anti-A and Anti-B (Group O) Blood Grouping Serum, 10ml bottle
Item 3 – Anti-B Blood Grouping Serum, 10ml bottle
Item 4 – Anti-D Blood Grouping Serum (RH 1), 10ml bottle

GPOR 2871916/08/20196/9/2019 12:00 PMhttp://discovery.ariba.com/rfx/7144958S2 or Higher No
GPOR 28619

​Item 1 – Anti-C Blood Grouping Serum (RH 2), 5ml bottle
Item 2 – Anti-c Blood Grouping Serum (RH 4), 5ml bottle
Item 3 – Anti-CDE Blood Grouping Serum (RH 2, 1, 3), 5ml bottle
Item 4 – Anti-E Blood Grouping Serum (RH 3), 5ml bottle
Item 5 – Anti-e Blood Grouping Serum (RH 5), 5ml bottle
Item 6 – Low Ionic Strength Saline (LISS) Solution, 10ml bottle

GPOR 2861916/08/20196/9/2019 12:00 PMhttp://discovery.ariba.com/rfx/7144902S2 or HigherNo
GPOR 28519

​Item 1 - Itraconazole 10mg/ml Oral Solution, 150ml bottle

GPOR 2851908/08/201930/8/2019 12:00 PMhttp://discovery.ariba.com/rfx/7024272S2 or HigherNo
GPOR 28419

​Item 1 - Recombinant Factor VIII 250 IU Injection
Item 2 - Recombinant Factor VIII 500 IU Injection
Item 3 - Recombinant Factor VIII 1000 IU Injection
Item 4 - Recombinant Factor VIII 1500 IU Injection
Item 5 - Recombinant Factor VIII 2000 IU Injection

GPOR 2841908/08/201930/8/2019 12:00 PMhttp://discovery.ariba.com/rfx/7113808S5 or HigherNo
GPOR 28319

​Item 1 - Recombinant Factor VIIa (Eptacog Alfa) 1mg Injection

GPOR 2831908/08/201930/8/2019 12:00 PMhttp://discovery.ariba.com/rfx/7113730S4 or HigherNo
GPOR 28219

​Item 1 - Recombinant Factor IX 500 IU Injection

GPRO 2821908/08/201930/8/2019 12:00 PMhttp://discovery.ariba.com/rfx/7113475S5 or HigherNo
GPOR 28119

Item 1 - Risedronate Sodium 150mg Tablets​

GPOR 2811908/08/201930/8/2019 12:00 PMhttp://discovery.ariba.com/rfx/7112234S2 or HigherNo
GPOR 28019

​Item 1 - Ambrisentan 5mg Tablets
Item 2 - Ambrisentan 10mg Tablets

GPOR 2801902/08/201920/8/2019 12:00 PMhttp://discovery.ariba.com/rfx/7085472S2 or HigherNo
GPOR 27919

​Item 1 - Infliximab 100mg Injection

GPOR 2791902/08/201923/8/2019 12:00 PMhttp://discovery.ariba.com/rfx/7085441S4 or HigherNo